Endologix Receives CE Mark Approval For Expanded Line Of Powerlink Products And PowerFit Aortic Extensions
Endologix, Inc. announced that it received CE Mark approval to market its expanded offering of Powerlink® stent graft products and PowerFit™ Aortic Extensions in the European Union. The Company expects to launch the products in a limited market release in Europe during the fourth quarter of 2010, followed by a full product launch in 2011. Endologix recently received U.S. Food and Drug Administration (FDA) approval for these new products and they are currently in a limited market release in the U.S., with a full market release in the U.S. planned for the fourth quarter of 2010.
Read the fulls story here
-
Abbott Receives 510(k) Clearance For CT/NG Assay And Abbott m2000 System
Cepheida receives approval for its bacterial diagnostic test
InfraScan receives CE Mark for handheld detector
Roche Receives FDA Clearance For U.S. Launch Of Cobas 8000 Modular Analyzer Series For High-Volume Laboratory Testing
Abbott Gets FDA Clearance For Molecular Diagnostic Test For Detection Of Chlamydia And Gonorrhea Infections
